Dynamic, inter-subunit interactions between the N-terminal and central mutation regions of cardiac ryanodine receptor

Journal of Cell Science

Volumn 123, Issue 10, 2010, Pages 1775-1784

  Liu, Zheng ^a   Wang, Ruiwu ^b   Tian, Xixi ^b   Zhong, Xiaowei ^b   Gangopadhyay, Jaya ^c   Cole, Richard ^a   Ikemoto, Noriaki ^c   Chen, S R Wayne ^b   Wagenknecht, Terence ^a  

^a WADSWORTH CENTER   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Ca2+ release channel; Inter subunit interaction; Ryanodine receptor; Sudden cardiac death; Ventricular arrhythmias

Indexed keywords

AZUMOLENE; CYAN FLUORESCENT PROTEIN; DANTROLENE; RYANODINE RECEPTOR; YELLOW FLUORESCENT PROTEIN; CALCIUM CHANNEL;

AMINO TERMINAL SEQUENCE; ARTICLE; CHANNEL GATING; CONFOCAL MICROSCOPY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEART ARRHYTHMIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUDDEN DEATH; BIOLOGICAL MODEL; CELL LINE; CHEMISTRY; COMPLICATION; DEATH, SUDDEN, CARDIAC; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART MUSCLE; METABOLISM; MOLECULAR CLONING; MUTATION; PROTEIN CONFORMATION; TRANSGENE;

ARRHYTHMIAS, CARDIAC; CALCIUM CHANNELS; CELL LINE; CLONING, MOLECULAR; DEATH, SUDDEN, CARDIAC; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; MUTATION; MYOCARDIUM; POLYMORPHISM, GENETIC; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TRANSGENES;

EID: 77952386724     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.064071     Document Type: Article

References (60)

1. Bers, D. M. (2001). Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, Netherlands: Kluwer Academic.
2. Blunck, R., McGuire, H., Hyde, H. C. and Bezanilla, F. (2008). Fluorescence detection of the movement of single KcsA subunits reveals cooperativity. Proc. Natl. Acad. Sci. USA 105, 20263-20268.
3. Bossuyt, J., Despa, S., Martin, J. L. and Bers, D. M. (2006). Phospholemman phosphorylation alters its fluorescence resonance energy transfer with the Na/K-ATPase pump. J. Biol. Chem. 281, 32765-32773. (Pubitemid 46036832)
4. 2+ release channel (ryanodine receptor) expressed in HEK293 cells. J. Biol. Chem. 272, 24234-24246.
5. 2+ sensor. J. Biol. Chem. 273, 14675-14678.
6. 2+ release channel (ryanodine receptor) in ryanodine interaction. Biophys. J. 82, 2436-2447.
7. Choi, G., Kopplin, L. J., Tester, D. J., Will, M. L., Haglund, C. M. and Ackerman, M. J. (2004). Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation 110, 2119-2124. (Pubitemid 39372488)
8. Choisy, S., Huchet-Cadiou, C. and Leoty, C. (2000). Differential effects of 4-chloro-m-cresol and caffeine on skinned fibers from rat fast and slow skeletal muscles. J. Pharmacol. Exp. Ther. 294, 884-893. (Pubitemid 30666837)
9. Dirksen, R. T. and Avila, G. (2005). Pathophysiology of muscle disorders linked to mutations in the skeletal muscle ryanodine receptor. In Ryanodine Receptors-Structure, Function and Dysfunction in Clinical Disease. New York: Springer Science and Business Media.
10. Doi, M., Yano, M., Kobayashi, S., Kohno, M., Tokuhisa, T., Okuda, S., Suetsugu, M., Hisamatsu, Y., Ohkusa, T., Kohno, M. et al. (2002). Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor. Circulation 105, 1374-1379. (Pubitemid 34260431)
11. 2+ release channels (ryanodine receptors) with a novel [3H]ryanodine binding assay. J. Biol. Chem. 273, 33259-33266.
12. 2+ release channel (ryanodine receptor). J. Biol. Chem. 275, 11778-11783.
13. Fessenden, J. D., Wang, Y., Moore, R. A., Chen, S. R. W., Allen, P. D. and Pessah, I. N. (2000). Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line. Biophys. J. 79, 2509-2525.
14. Fessenden, J. D., Feng, W., Pessah, I. N. and Allen, P. D. (2006). Amino acid residues Gln4020 and Lys4021 of the ryanodine receptor type 1 are required for activation by 4-chloro-m-cresol. J. Biol. Chem. 281, 21022-21031. (Pubitemid 44115443)
15. Hamada, T., Gangopadhyay, J. P., Mandl, A., Erhardt, P. and Ikemoto, N. (2009). Defective regulation of the ryanodine receptor induces hypertrophy in cardiomyocytes. Biochem. Biophys. Res. Comm. 380, 493-497.
16. Hamilton, S. L. and Serysheva, I. I. (2009). Ryanodine receptor structure: progress and challenges. J. Biol. Chem. 284, 4047-4051.
17. Herrmann-Frank, A., Richter, M., Sarközi, S., Mohr, U. and Lehmann-Horn, F. (1996). 4-chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor. Biochim. Biophys. Acta 1289, 31-40. (Pubitemid 26075668)
18. Ikemoto, N. and Yamamoto, T. (2002). Regulation of calcium release by interdomain interaction within ryanodine receptors. Front. Biosci. 7, D659-D670.
19. Jefferson, D., Jenner, P. and Marsden, C. D. (1979). Relationship between plasma propranolol concentration and relief of essential tremor. J. Neurol. Neurosurg. Psychiatry 42, 831-837. (Pubitemid 9245260)
20. Jones, P. P., Meng, X., Xiao, B., Cai, S., Bolstad, J., Wagenknecht, T., Liu, Z. and Chen, S. R. W. (2008). Localization of PKA phosphorylation site, Ser2030, in the three-dimensional structure of cardiac ryanodine receptor. Biochem. J. 410, 261-270. (Pubitemid 351346184)
21. Kobayashi, S., Bannister, M. L., Gangopadhyay, J. P., Hamada, T., Parness, J. and Ikemoto, N. (2005). Dantrolene stabilizes domain interactions within the ryanodine receptor. J. Biol. Chem. 280, 6580-6587. (Pubitemid 40341208)
22. Kobayashi, S., Yano, M., Suetomi, T., Ono, M., Tateishi, H., Mochizuki, M., Xu, X., Uchinoumi, H., Okuda, S., Yamamoto, T. et al. (2009). Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. J. Am. Coll. Cardiol. 53, 1993-2005.
23. 2+ activation of the ryanodine receptor. Biochem. J. 414, 441-452.
24. Laitinen, P. J., Brown, K. M., Piippo, K., Swan, H., Devaney, J. M., Brahmbhatt, B., Donarum, E. A., Marino, M., Tiso, N., Viitasalo, M. et al. (2001). Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103, 485-490. (Pubitemid 32116230)
25. 2+ release in skinned skeletal muscle fibers. Am. J. Physiol. Cell Physiol. 281, C207-C214.
26. Liu, Z., Wang, R., Zhang, J., Chen, S. R. W. and Wagenknecht, T. (2005). Localization of a disease-associated mutation site in the three-dimensional structure of the cardiac muscle ryanodine receptor. J. Biol. Chem. 280, 37941-37947. (Pubitemid 41642407)
27. Liu, Z., Wang, R., Chen, S. R. W. and Wagenknecht, T. (2006). The amino-terminal and central mutation hotspots are adjacent to each other in the three-dimensional structure of RyR2 as revealed by cryo-electron microscopy. Biophys. J. 90, 389.
28. 2+ activation. J. Biol. Chem. 276, 39727-39735.
29. Ochs, H. R. and Knuchel, M. (1984). Pharmacokinetics and absolute bioavailability of diltiazem in humans. J. Mol. Med. 62, 303-306. (Pubitemid 14167952)
30. Papadopoulos, S., Leuranguer, V., Bannister, R. A. and Beam, K. G. (2004). Mapping sites of potential proximity between the dihydropyridine receptor and RyR1 in muscle using a cyan fluorescent protein-yellow fluorescent protein tandem as a fluorescence resonance energy transfer probe. J. Biol. Chem. 279, 44046-44056. (Pubitemid 39390714)
31. Paul-Pletzer, K., Palnitkar, S. S., Jimenez, L. S., Morimoto, H. and Parness, J. (2001). The skeletal muscle ryanodine receptor identified as a molecular target of [3H]azidodantrolene by photoaffinity labeling. Biochemistry 40, 531-542. (Pubitemid 32062001)
32. Paul-Pletzer, K., Yamamoto, T., Bhat, M. B., Ma, J., Ikemoto, N., Jimenez, L. S., Morimoto, H., Williams, P. G. and Parness, J. (2002). Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J. Biol. Chem. 277, 34918-34923.
33. Paul-Pletzer, K., Yamamoto, T., Ikemoto, N., Jimenez, L. S., Morimoto, H., Williams, P. G., Ma, J. and Parness, J. (2005). Probing a putative dantrolene-binding site on the cardiac ryanodine receptor. Biochem. J. 387, 905-909. (Pubitemid 40685728)
34. Priori, S. G., Napolitano, C., Tiso, N., Memmi, M., Vignati, G., Bloise, R., Sorrentino, V. and Danieli, G. A. (2001). Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103, 196-200. (Pubitemid 32095402)
35. Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., DeSimone, L., Coltorti, F., Bloise, R., Keegan, R. et al. (2002). Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106, 69-74. (Pubitemid 34747444)
36. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., Kissela, B. et al. (2008). Heart disease and stroke statistics-2008 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 117, e25-e146.
37. Samso, M., Wagenknecht, T. and Allen, P. D. (2005). Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-EM. Nat. Struct. Mol. Biol. 12, 539-544. (Pubitemid 43085885)
38. Samso, M., Feng, W., Pessah, I. N. and Allen, P. D. (2009). Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol. 7, e1000085.
39. 2+ and AMPPCP. Biophys. J. 77, 1936-1944.
40. Serysheva, I. I., Ludtke, S. J., Baker, M. L., Cong, Y., Topf, M., Eramian, D., Sali, A., Hamilton, S. L. and Chiu, W. (2008). Subnanometer- resolution electron cryomicroscopy-based domain models for the cytoplasmic region of skeletal muscle RyR channel. Proc. Natl. Acad. Sci. USA 105, 9610-9615. (Pubitemid 352031348)
41. Sharma, M. R., Jeyakumar, L. H., Fleischer, S. and Wagenknecht, T. (2006). Three-dimensional visualization of FKBP12.6 binding to an open conformation of cardiac ryanodine receptor. Biophys. J. 90, 164-172.
42. 2+ spark frequency in skeletal muscle. J. Gen. Physiol. 119, 15-32.
43. Sitsapesan, R. and Williams, A. J. (1990). Mechanisms of caffeine activation of single calcium-release channels of sheep cardiac sarcoplasmic reticulum. J. Physiol. 423, 425-439. (Pubitemid 20137767)
44. Swan, H., Laitinen, P., Kontula, K. and Toivonen, L. (2005). Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations. J. Cardiovasc. Electrophys. 16, 162-166. (Pubitemid 40326272)
45. Tester, D. J., Spoon, D. B., Valdivia, H. H., Makielski, J. C. and Ackerman, M. J. (2004). Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: A molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin. Proc. 79, 1380-1384.
46. 2+ release from skeletal and cardiac muscle sarcoplasmic reticulum. BBA - Mol. Cell Res. 1094, 27-34.
47. Valdivia, H. H., Valdivia, C., Ma, J. and Coronado, R. (1990). Direct binding of verapamil to the ryanodine receptor channel of sarcoplasmic reticulum. Biophys. J. 58, 471-481. (Pubitemid 20249674)
48. Vogelgesang, B., Echizen, H., Schmidt, E. and Eichelbaum, M. (1984). Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. Br. J. Clin. Pharmacol. 18, 733-740. (Pubitemid 15209203)
49. Wakimoto, H., Alcalai, R., Song, L., Arad, M., Seidman, C. E., Seidman, J. G. and Berul, C. I. (2007). Prevention of fatal arrhythmia in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation. Circulation 116, 216.
50. 2+ release channel (ryanodine receptor) is critical for ryanodine interaction. J. Biol. Chem. 278, 51557-51565.
51. Wang, R., Chen, W., Cai, S., Zhang, J., Bolstad, J., Wagenknecht, T., Liu, Z. and Chen, S. R. W. (2007). Localization of an NH2-terminal disease-causing mutation hot spot to the "clamp" region in the three-dimensional structure of the cardiac ryanodine receptor. J. Biol. Chem. 282, 17785-17793.
52. Welch, W., Rheault, S., West, D. J. and Williams, A. J. (2004). A model of the putative pore region of the cardiac ryanodine receptor channel. Biophys. J. 87, 2335-2351. (Pubitemid 41071334)
53. Yamamoto, T. and Ikemoto, N. (2002). Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor. Biochem. Biophys. Res. Comm. 291, 1102-1108. (Pubitemid 34694387)
54. 2+ channel regulation. J. Biol. Chem. 275, 11618-11625.
55. Yano, M., Kobayashi, S., Kohno, M., Doi, M., Tokuhisa, T., Okuda, S., Suetsugu, M., Hisaoka, T., Obayashi, M., Ohkusa, T. et al. (2003). FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107, 477-484. (Pubitemid 36158052)
56. Yano, M., Yamamoto, T., Ikemoto, N. and Matsuzaki, M. (2005). Abnormal ryanodine receptor function in heart failure. Pharmacol. Ther. 107, 377-391. (Pubitemid 41175911)
57. Zchut, S., Feng, W. and Shoshan-Barmatz, V. (1996). Ryanodine receptor/calcium release channel conformations as reflected in the different effects of propranolol on its ryanodine binding and channel activity. Biochem. J. 315, 377-383. (Pubitemid 26129481)
58. Zhang, J., Liu, Z., Masumiya, H., Wang, R., Jiang, D., Li, F., Wagenknecht, T. and Chen, S. R. W. (2003). Three-dimensional localization of divergent region 3 of the ryanodine receptor to the clamp-shaped structures adjacent to the FKBP binding sites. J. Biol. Chem. 278, 14211-14218. (Pubitemid 36799969)
59. Zhao, M., Li, P., Li, X., Zhang, L., Winkfein, R. J. and Chen, S. R. W. (1999). Molecular identification of the ryanodine receptor pore-forming segment. J. Biol. Chem. 274, 25971-25974. (Pubitemid 129520013)
60. Zhou, Q., Wang, Q. L., Meng, X., Shu, Y., Jiang, T., Wagenknecht, T., Yin, C. C., Sui, S. F. and Liu, Z. (2008). Structural and functional characterization of ryanodine receptor-natrin toxin interaction. Biophys. J. 95, 4289-4299.